Skip to content

Enhancing Motor Learning in Children With Cerebral Palsy Using Transcranial Direct-current Stimulation

Enhancing Motor Learning in Children With Cerebral Palsy Using Transcranial Direct-current Stimulation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04725019
Enrollment
60
Registered
2021-01-26
Start date
2021-08-01
Completion date
2026-07-31
Last updated
2021-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Brief summary

The goal of this study is to test the effects of transcranial direct current stimulation (tDCS) on motor learning and brain plasticity in children with unilateral spastic cerebral palsy (USCP).

Interventions

DEVICEactive transcranial direct current stimulation

Participants will receive 20 min of tDCS over the scalp during 20 min of motor training.

BEHAVIORALMotor training

Participants will engage in a high number of repetition of movements that use both hands while playing with toys and games. Training will be provided 20 min/day, for 5 consecutive days.

Sponsors

Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

Children between 6-17 years old who have been diagnosed with cerebral palsy, with the following joint mobility: wrist extension 20º, metacarpophalangeal and proximal interphalangeal joints 10º. Ability to cooperate and follow simple directions.

Exclusion criteria

* Seizure beyond age 2, use of anti-seizure medication, history or family history of epilepsy, cranial metal implants, structural brain lesion, devices that may be affected by tDCS or TMS (pacemaker, medication pump, cochlear implant, implanted brain stimulator) * True positive response on the Transcranial Magnetic Stimulation and MRI Safety Screen * Current use of medications known to lower the seizure threshold * Previous episode of unprovoked neurocardiogenic syncope * Indwelling metal or incompatible medical devices * Centrally-acting medications including anti-seizure medications * Evidence of scalp disease or skin abnormalities * Current medical illness unrelated to CP * High motor ability in affected arm (i.e. no asymmetry in scores of hand function) * Severe spasticity * Lack of asymmetry in hand function * Orthopedic surgery in affected arm * Botulinum toxin therapy in either upper extremity during last 6 months, or planned during study period * Currently receiving intrathecal baclofen * History of broken arm (either arm) 1 year prior to study enrollment

Design outcomes

Primary

MeasureTime frameDescription
Changes in the Assisting Hand AssessmentDay before intervention begins, compared to day after intervention ends (approximately 1 week)Investigators will measure changes in how well the child uses both hands cooperatively for bimanual activities.
Changes in the Box and Blocks testDay before intervention begins, compared to day after intervention ends (approximately 1 week)Investigators will measure changes in the movement speed of the hands.

Secondary

MeasureTime frameDescription
Changes in Motor-evoked Potential assessmentDay before intervention begins, compared to day after intervention ends (approximately 1 week)Investigators will measure change in measurements of cortical excitability using transcranial magnetic stimulation (TMS) from baseline to follow-up (1 week).

Contacts

Primary ContactClaudio L Ferre, PhD
clferre@bu.edu(617) 353-7489

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026